Holen Sie sich die Stockscreener-App
2.38
3.64%
-0.09
Schlusskurs vom Vortag:
$2.47
Offen:
$2.41
24-Stunden-Volumen:
195.69K
Relative Volume:
0.71
Marktkapitalisierung:
$17.94M
Einnahmen:
$14.58M
Nettoeinkommen (Verlust:
$-12.57M
KGV:
-0.419
EPS:
-5.68
Netto-Cashflow:
$-13.07M
1W Leistung:
-8.46%
1M Leistung:
-25.39%
6M Leistung:
-12.82%
1J Leistung:
-11.52%
1-Tages-Spanne:
$2.37
$2.58
1-Wochen-Bereich:
$2.37
$2.88
52-Wochen-Spanne:
$1.98
$7.95
Vivos Therapeutics Inc Stock (VVOS) Company Profile
Firmenname
Vivos Therapeutics Inc
Sektor
Branche
Telefon
(866)908-4867
Adresse
7921 SOUTHPARK PLAZA,, LITTLETON
Vergleichen Sie VVOS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
2.39 | 18.54M | 14.58M | -12.57M | -13.07M | -5.68 |
|
ABT
Abbott Laboratories
|
125.27 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.45 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
361.60 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.05 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.01 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
Vivos Therapeutics Inc Aktie (VVOS) Neueste Nachrichten
Will Vivos Therapeutics Inc. continue its uptrend2025 Institutional Moves & AI Powered Buy and Sell Recommendations - newser.com
What technical charts say about Vivos Therapeutics Inc. stockVolume Spike & Free Daily Entry Point Trade Alerts - newser.com
Is Vivos Therapeutics Inc. stock a contrarian buyMarket Risk Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Vivos Therapeutics Inc. stock a safe haven assetGold Moves & Fast Entry Momentum Trade Alerts - newser.com
Forecasting Vivos Therapeutics Inc. price range with options dataJuly 2025 Reactions & High Accuracy Investment Signals - newser.com
Will Vivos Therapeutics Inc. see short term momentum2025 Volume Leaders & Verified Entry Point Signals - newser.com
How to recover losses in Vivos Therapeutics Inc. stockBull Run & Daily Risk Controlled Trade Plans - newser.com
How risky is Vivos Therapeutics Inc. stock nowJuly 2025 Big Picture & Real-Time Chart Breakout Alerts - newser.com
Vivos Therapeutics Inc. stock momentum explainedEarnings Recap Report & Technical Confirmation Trade Alerts - newser.com
Why Vivos Therapeutics Inc. stock appeals to analystsRecession Risk & Long-Term Capital Growth Strategies - newser.com
Is Vivos Therapeutics Inc. stock undervalued vs historical averages2025 Market Trends & Verified Trade Idea Suggestions - newser.com
Vivos Therapeutics Inc. recovery potential after sell offJuly 2025 Big Picture & Reliable Entry Point Trade Alerts - newser.com
Best Momentum Stocks to Buy for January 8th - MSN
Vivos Therapeutics Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
How supply chain issues affect Vivos Therapeutics Inc. stockBuy Signal & Growth Oriented Trade Recommendations - newser.com
How Vivos Therapeutics Inc. stock benefits from global expansion2025 Valuation Update & Daily Chart Pattern Signal Reports - newser.com
Study: Vivos Therapeutics Sleep Apnea Device Helps Improve Pediatric ADHD - Medical Product Outsourcing
What institutional flow reveals about Vivos Therapeutics Inc.Market Activity Recap & Community Verified Watchlist Alerts - newser.com
Using Ichimoku Cloud for Vivos Therapeutics Inc. technicalsShare Buyback & Free Weekly Watchlist of Top Performers - newser.com
Using portfolio simulators with Vivos Therapeutics Inc. includedMarket Performance Recap & Verified Technical Trade Signals - newser.com
Can Vivos Therapeutics Inc. rally from current levelsJuly 2025 Rallies & Technical Pattern Alert System - newser.com
Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics - MarketScreener
Vivos (OTCQB: RDGL) and Exubrion expand collaboration on targeted radioisotopes - Stock Titan
Can Vivos Therapeutics Inc. stock surprise with earnings upsideCPI Data & Weekly Setup with High ROI Potential - newser.com
Finanzdaten der Vivos Therapeutics Inc-Aktie (VVOS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):